FDA Approves Gene Therapy for Rare Form of Blindness

TUESDAY, Dec. 19, 2017 — A new gene therapy to treat children and adults with a rare type of inherited vision loss has been approved by the U.S. Food and Drug Administration.
It’s the first gene therapy approved in the United States for a disease…
Source: Topamax